000 | 01993 a2200541 4500 | ||
---|---|---|---|
005 | 20250518035007.0 | ||
264 | 0 | _c20200831 | |
008 | 202008s 0 0 eng d | ||
022 | _a1461-7005 | ||
024 | 7 |
_a10.1177/1362361318824103 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHardan, Antonio Y | |
245 | 0 | 0 |
_aEfficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies. _h[electronic resource] |
260 |
_bAutism : the international journal of research and practice _c11 2019 |
||
300 |
_a2096-2111 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAutism Spectrum Disorder _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aEarly Termination of Clinical Trials |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xchemically induced |
650 | 0 | 4 |
_aHeadache _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIrritable Mood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemantine _xtherapeutic use |
650 | 0 | 4 |
_aNasopharyngitis _xchemically induced |
650 | 0 | 4 | _aSocial Behavior |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aHendren, Robert L | |
700 | 1 | _aAman, Michael G | |
700 | 1 | _aRobb, Adelaide | |
700 | 1 | _aMelmed, Raun D | |
700 | 1 | _aAndersen, Kristen A | |
700 | 1 | _aLuchini, Rachel | |
700 | 1 | _aRahman, Rezwanur | |
700 | 1 | _aAli, Sanjida | |
700 | 1 | _aJia, X Daniel | |
700 | 1 | _aMallick, Madhuja | |
700 | 1 | _aLateiner, Jordan E | |
700 | 1 | _aPalmer, Robert H | |
700 | 1 | _aGraham, Stephen M | |
773 | 0 |
_tAutism : the international journal of research and practice _gvol. 23 _gno. 8 _gp. 2096-2111 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1362361318824103 _zAvailable from publisher's website |
999 |
_c29630157 _d29630157 |